Opioid Use Disorder, Severe
8
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy
Family-Focused Study to Support Medication for Opioid Use Disorder
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
EXHIT ENTRE Comparative Effectiveness Trial
SUBLOCADE Rapid Initiation Extension Study
A Brief Negotiation Interview Chatbot to Improve Buprenorphine Engagement Among Justice-Involved Individuals
Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders
Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder